Loading clinical trials...
Loading clinical trials...
Among the objective non-invasive audiological explorations the distorsion products of otoacoustic emissions (DPOAE) allow to quickly assess the function of the cochlear outer hair cells (without the active participation of the subject). This technique is used in newborn screening. While humans are able to perceive sounds in a frequency range of 20Hz to 20kHz, routine clinical audiological assessment is only concerned with frequencies between 1-4kHz. This obscures the importance of high frequencies (HF) which can be easily assessed by DPOAEs. In young children, the perception of these high frequencies could also play an important role in language acquisition. The main objective of this study is to evaluate the relationship between subtle high-frequency hearing impairment, as assessed by the DPOAE (non-invasive, rapid and simple audiological test), and language delay or difficulties in a pre-, peri- and school-age pediatric population.
Age
2 - 17 years
Sex
ALL
Healthy Volunteers
Yes
CHU Clermont-Ferrand, UMR INSERM 1107
Clermont-Ferrand, France
Start Date
January 1, 2023
Primary Completion Date
July 1, 2027
Completion Date
July 1, 2027
Last Updated
November 22, 2022
138
ESTIMATED participants
acoustic otoemisions
DIAGNOSTIC_TEST
Otoscopy
DIAGNOSTIC_TEST
Audiometry
DIAGNOSTIC_TEST
Tympanometry
DIAGNOSTIC_TEST
Lead Sponsor
University Hospital, Clermont-Ferrand
NCT05921214
NCT05921227
NCT05921188
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions